DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2plqwb/hypercholesterolem) has announced the addition of the "Hypercholesterolemia Partnering 2009-2014" report to their offering.
Hypercholesterolemia Partnering 2009-2014 provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the world's leading healthcare companies.
The report provides an analysis of hypercholesterolemia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors hypercholesterolemia technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of hypercholesterolemia technologies and products.
Hypercholesterolemia Partnering 2009-2014 is intended to provide the reader with an in-depth understanding and access to hypercholesterolemia trends and structure of deals entered into by leading companies worldwide.
This data driven report includes:
- Trends in hypercholesterolemia dealmaking in the biopharma industry since 2009
- Access to summary headline, upfront, milestone and royalty data
- Access to over 25 hypercholesterolemia contract documents
- The leading hypercholesterolemia deals by value since 2009
In Hypercholesterolemia Partnering 2009-2014, the available deals are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Company A-Z
- Industry sector
- Stage of development at signing
- Deal component type
- Technology type
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in hypercholesterolemia partnering
Chapter 3 - Leading hypercholesterolemia deals
Chapter 4 - Dealmaking directory
Chapter 5 - Partnering resource center
For more information visit http://www.researchandmarkets.com/research/2plqwb/hypercholesterolem